The Veterinary Infectious Disease Diagnostics Market is estimated to be valued at USD 2.3 billion in 2025 and is projected to reach USD 6.0 billion by 2035, registering a compound annual growth rate (CAGR) of 10.1% over the forecast period.
| Metric | Value |
|---|---|
| Veterinary Infectious Disease Diagnostics Market Estimated Value in (2025 E) | USD 2.3 billion |
| Veterinary Infectious Disease Diagnostics Market Forecast Value in (2035 F) | USD 6.0 billion |
| Forecast CAGR (2025 to 2035) | 10.1% |
The veterinary infectious disease diagnostics market is expanding steadily due to the rising prevalence of zoonotic diseases, growing pet ownership, and heightened awareness around animal health and welfare. Advancements in molecular and immunodiagnostic technologies are enabling earlier detection of infections, thereby improving treatment outcomes and limiting disease spread.
Increasing expenditure on companion animal healthcare, combined with the adoption of preventive care practices, is boosting demand for rapid and reliable diagnostic solutions. Furthermore, regulatory frameworks that emphasize biosecurity and livestock health management are driving adoption across veterinary clinics and laboratories.
The market outlook remains positive as stakeholders focus on early diagnosis, precision medicine for animals, and integrated laboratory services to improve both pet and livestock healthcare outcomes.
The market is segmented by Technology, Animal Type, and End User and region. By Technology, the market is divided into Immunodiagnostics, Molecular Diagnostic, and Others. In terms of Animal Type, the market is classified into Companion Animal and Food-producing Animals. Based on End User, the market is segmented into Reference Laboratories, Veterinary Hospitals & Clinics, Point-of-Care, and Research Institutes & Universities. Regionally, the market is classified into North America, Latin America, Western Europe, Eastern Europe, Balkan & Baltic Countries, Russia & Belarus, Central Asia, East Asia, South Asia & Pacific, and the Middle East & Africa.
The immunodiagnostics segment is projected to hold 47.60% of total revenue within the technology category, making it the leading segment. This dominance is driven by its high accuracy, cost effectiveness, and ability to detect a wide range of pathogens rapidly.
Immunoassays are valued for their ease of use in veterinary settings, as they require minimal specialized equipment while delivering reliable results. Their widespread availability and adaptability to both companion and livestock animals have supported their continued adoption.
Ongoing advancements in assay sensitivity and automation are further enhancing performance, reinforcing immunodiagnostics as the preferred technology in veterinary infectious disease diagnostics.
The companion animal category is expected to account for 55.30% of the market under the animal type segment, reflecting its leadership position. This growth is being fueled by the rising trend of pet humanization, increased veterinary healthcare expenditure, and strong demand for routine diagnostics to ensure pet well being.
The prevalence of infectious diseases in cats and dogs has highlighted the importance of timely testing, encouraging veterinarians and pet owners to rely on advanced diagnostic kits. Additionally, growing insurance coverage for companion animals has supported higher diagnostic adoption.
These factors combined are positioning companion animals as the primary growth driver in this market.
The reference laboratories segment is projected to represent 42.80% of market revenue within the end user category, establishing it as the dominant segment. This is due to their capacity to provide high throughput, advanced testing with greater accuracy compared to point of care settings.
Reference laboratories are increasingly relied upon for confirmatory diagnostics and specialized infectious disease panels, especially in complex cases. Their ability to handle a large volume of samples with standardized protocols ensures reliability and consistency.
Strategic investments in automation, molecular platforms, and global diagnostic networks have further strengthened their market position, making reference laboratories the cornerstone of veterinary infectious disease diagnostics.
According to a Future Market Insights analysis, the global market for veterinary infectious disease diagnostics has lately expanded dramatically. Top competitors in the industry are collaborating to fulfill increased demand for veterinary infectious disease diagnostics. The estimated CAGR, which was 11.9% from 2020 to 2025, is expected to fall to 10.1%.
Over the last few years, there has been a rapid surge in pet adoption, especially across developed and developing countries like the USA France, China, Germany, India, etc. This is acting as a catalyst for the growth of the veterinary infectious disease diagnostics market, and the trend is likely to follow during the forecast period.
Similarly, rising concerns regarding the spread of infectious diseases from animals to humans are providing an impetus to the growth of the veterinary infectious disease diagnostic market. According to the Centers for Disease Control and Prevention (CDC), scientists have estimated that around more than 6 out of every 10 known infectious diseases in people can be spread by animals.
Sales of rapid diagnostic tests for infectious diseases are mostly rising across developed countries due to increasing pet adoption and the flourishing animal healthcare market. However, demand for veterinary diagnostics is expected to grow at a substantial pace in emerging economies during the forecast period, owing to the increasing pet adoption, favorable government support, and increasing farm animal population.
Subsequently, the rapid expansion of veterinary hospitals and veterinary clinics, coupled with an increase in the number of veterinary practitioners and animal diseases diagnostic laboratories, is likely to further boost the growth of the veterinary infectious disease diagnostics market during the forthcoming years.
The expansion of the infectious animal diseases market size and burgeoning demand for veterinary diagnostics may create lucrative opportunities-leading market players in the future.
Sales of immunodiagnostics remain high in the global veterinary infectious disease diagnostics market.
Based on technology, the immunodiagnostics segment leads the global veterinary infectious disease diagnostics market in 2025 and is forecast to grow at a robust CAGR over the assessment period. Growing end-user preference for immunodiagnostics technology due to its various advantages is a key factor triggering the growth of this segment.
The increasing prevalence of animal diseases, coupled with rising immunodiagnostics sales, is anticipated to provide lucrative opportunities for market players during the forecast period.
Demand for Veterinary Infectious Disease Diagnostics Remains High in Companion Animal Category
Based on animal type, the companion animal segment is likely to grow at a relatively higher CAGR over the forecast period, owing to the rising pet adoption across developed and developing regions, increasing penetration of pet insurance, and increasing need for early detection and treatment of animal disease to eliminate the risk of disease spread.
Moreover, the expansion of markets like the pet care market and companion animals vaccines market is also favoring the growth of this segment.
Based on end users, the veterinary reference laboratories segment accounts for the leading revenue share in the global veterinary infectious disease diagnostics market. This is attributable to the increase in the number of veterinary practitioners, growing pet adoption rates, and the rapid expansion of the veterinary reference laboratory market.
On a global basis, an increase in the total number of companion animals and their rate of adoption has been noted. Numerous studies have found links between pet ownership and good health, including the normalization of blood pressure, fewer cardiac arrhythmias, increased psychological stabilization, reduced anxiety, and enhanced well-being.
The demand for pet care goods and services is anticipated to rise in response to the rising pet population, which is likely to in turn fuel the expansion of related sectors, such as the veterinary infectious disease diagnostics market globally.
For example, in North America, a pet was owned by 68% of US homes or around 2.1 million families, as per the American Pet Products Association's (APPA) National Pet Owners Survey (2024–2024). Also, 43 million families had cats, 64 million had dogs, and 1.7 billion had all three. Thus, with such skyrocketing demand for pets, the need for veterinary infectious diseases diagnostics is expected to be growing rapidly too.
Despite its optimistic stance, the global veterinary infectious diseases diagnostics market is facing various obstacles that are challenging its growth. Some of these obstacles are the increasing cost of veterinary treatment, poor availability of advanced veterinary disease diagnostic laboratories across low economies, and lack of pet insurance policies in some regions.
| Country | United States |
|---|---|
| CAGR (2025 to 2035) | 9.8% |
| CAGR (2020 to 2025) | 14% |
| Country | United Kingdom |
|---|---|
| CAGR (2025 to 2035) | 9.1% |
| CAGR (2020 to 2025) | 13% |
| Country | Japan |
|---|---|
| CAGR (2025 to 2035) | 9.4% |
| CAGR (2020 to 2025) | 13.6% |
| Country | South Korea |
|---|---|
| CAGR (2025 to 2035) | 8.5% |
| CAGR (2020 to 2025) | 12.5% |
| Country | Australia |
|---|---|
| CAGR (2025 to 2035) | 8.1% |
| CAGR (2020 to 2025) | 11.4% |
| Attributes | Details |
|---|---|
| US Market Size (2035) | USD1.7 billion |
| US Market Absolute Dollar Growth (USD Million/Billion) | USD 3 billion |
The veterinary infectious disease diagnostics market is dominated by the United States, which accounts for 9.8% of total North American sales. The veterinary infectious disease diagnostics market in the United States is expected to reach a peak of USD 1.7 billion.
The region's veterinary healthcare expenditure has increased significantly, which is likely to fuel market growth. Furthermore, the availability of healthcare programs and an increase in the number of efforts to enhance animal health are elements that are expected to increase the region's growth potential.
The purpose of veterinary diagnostics in the United States is to create ways to battle animal infections and zoonoses, while also helping the sensible use of antibiotics in veterinary medicine. Time-to-diagnosis and treatment accuracy are critical components of case management, as are infection control, the battle against multi-drug resistance, and the reduction of animal healthcare expenditures.
Key players provide a full variety of animal health solutions based on manual or automated technologies, from sample to decision. Market participants provide a diverse range of ELISA and RIA kits for veterinary diagnostics. Their principal products include salivary diagnostics, as well as assays for viral illnesses, autoimmunity, biogenic amines, and tumor markers.
They work to enhance the health and comfort of dogs suffering from neurologic illness. This is accomplished by combining the art of compassionate care with the science of veterinary neurology.
The relevance of animal health bioanalysis is recognized by key players. Key players are happy to support the creative work being done, from improving therapeutic capacities for precious pets to ensuring the food they ingest is safe.
With innovative solutions in pet diagnostics in the country, pet owners can be certain that their analytic requirements are met with the utmost care and attention.
| Attributes | Details |
|---|---|
| United Kingdom Market Size (2035) | USD 206.2 million |
| United Kingdom Market Absolute Dollar Growth (USD Million/Billion) | USD 120 million |
The United Kingdom is a substantial veterinary infectious disease diagnostics market, with an expected value of USD 206.2 million and a revenue growth rate of 9.1% during the forecast period. Key stakeholders in helping pet owners hope to better educate them by providing a variety of materials. These enable pet owners to make educated decisions about their pet's health. Moreover, their website is meant to be an intriguing and educational veterinary health reference.
The research and development operations of key players in the United Kingdom guarantee that their products represent cutting-edge RT-PCR and ELISA technology. Furthermore, they guarantee that the goods enable them to constantly launch fresh, inventive experiments.
To stay ahead of the curve in infectious disease diagnostics, they reinvest 30% of their revenue in research and development initiatives, collaborate with premier experts and reference laboratories throughout the world, and engage in European research programs.
The primary focus of research centers is to provide creative solutions, tests, samples, and so on for veterinary needs. For instance, the University of Glasgow's Veterinary Diagnostic Services department is dedicated to processing all data clearly and transparently, as well as securely keeping and disposing of all data following GDPR rules.
On request, they can provide complimentary swabs, viral transfer medium, submission forms, and prepaid postal labels. In addition, laboratory findings are confirmed by veterinary consultants before being communicated to the submitting veterinarian practice.
| Attributes | Details |
|---|---|
| Japan Market Size (2035) | USD 351.6 million |
| Japan Market Absolute Dollar Growth (USD Million/Billion) | USD 208.9 million |
Japan accounts for 9.4% of overall revenues in the veterinary infectious disease diagnostics market. The Japanese veterinary infectious disease diagnostics market is worth USD 351.6 million. This is attributed to the increasing acceptability of companion animals. Additionally, there is a significant need for animal proteins in the country, which is projected to drive regional market expansion.
Key players in Japan concentrate on a wide spectrum of bacterial and parasite illnesses of domestic animals, including zoonosis. Moreover, biosensor technologies are being tested for use in determining the health condition of individual animals.
Key players in Japan are providing diagnostic services employing new technology to diagnose novel illnesses, especially exotic diseases, to enhance animal health. This is done in response to requests from Japan's national and municipal governments.
| Attributes | Details |
|---|---|
| Australia Market Size (2035) | USD174.1million |
| Australia Market Absolute Dollar Growth (USD Million/Billion | USD 94.1 million |
Australia is a very profitable veterinary infectious disease diagnostics market, with a revenue growth rate of 8.1% and a projected value of USD 174.1 million during the projection year. Key players and research institutions in the country are investigating methods to improve the welfare of pets and livestock. They accomplish this by establishing scientific tools for analyzing how animals' feelings are affected by standard management practices.
Key players in the country supply animals with complicated illnesses with inexpensive, world-class medical, surgical, and emergency care. For instance, one market participant collaborates with both pet owners and veterinarians to give treatment at vet clinics around Greater Sydney via their mobile service. They claim to collaborate with veterinarians to give the best possible care for the owner's pet.
Many animal problems are detected, diagnosed, and solved by Australian market players in collaboration with veterinarians and animal health officials. Furthermore, they collaborate with primary farmers and industry to find creative solutions to issues. Certain key players, for instance, have employed a 3D scanner to get an accurate image of a horse's Laminitis-affected hoof. They then successfully tailored a 3D-printed shoe to support and heal the hoof.
With an aging pet population and accompanying age-related disorders, there are few novel and natural therapies to assist in giving treatment for problems like osteoarthritis. As a result, important manufacturers discovered a market gap for natural plant-derived animal medicines that are both safe and effective. This is done largely to promote greater health and well-being for companion animals, with a concentration on cannabis-derived chemicals.
Start-up companies are offering veterinary solutions that are incorporated with artificial intelligence (AI), which is contributing to the global veterinary infectious disease diagnostics market growth:
Due to the presence of multiple established competitors, the veterinary infectious disease diagnostics market share is very competitive. To capitalize on market growth potential, these firms are focusing on increasing their reach through acquisitions, expansions, product approvals, and launches.
Recent Developments:
The global veterinary infectious disease diagnostics market is estimated to be valued at USD 2.3 billion in 2025.
The market size for the veterinary infectious disease diagnostics market is projected to reach USD 6.0 billion by 2035.
The veterinary infectious disease diagnostics market is expected to grow at a 10.1% CAGR between 2025 and 2035.
The key product types in veterinary infectious disease diagnostics market are immunodiagnostics, molecular diagnostic and others.
In terms of animal type, companion animal segment to command 55.3% share in the veterinary infectious disease diagnostics market in 2025.
Explore Similar Insights
Veterinary Infectious Disease Diagnostics Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
